MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 216 filers reported holding MEDIVATION INC in Q4 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $41,735,000 | +27.4% | 692,125 | -2.8% | 0.01% | +30.0% |
| Q1 2016 | $32,751,000 | -18.6% | 712,292 | -14.4% | 0.01% | -16.7% |
| Q4 2015 | $40,244,000 | +14.5% | 832,510 | +0.6% | 0.01% | +9.1% |
| Q3 2015 | $35,158,000 | -9.4% | 827,240 | +143.4% | 0.01% | 0.0% |
| Q2 2015 | $38,818,000 | -15.5% | 339,905 | -4.5% | 0.01% | -8.3% |
| Q1 2015 | $45,959,000 | +38.2% | 356,074 | +6.7% | 0.01% | +33.3% |
| Q4 2014 | $33,250,000 | +0.3% | 333,803 | -0.5% | 0.01% | 0.0% |
| Q3 2014 | $33,166,000 | -31.9% | 335,454 | -46.9% | 0.01% | +28.6% |
| Q2 2014 | $48,712,000 | +144.4% | 631,968 | +104.1% | 0.01% | +40.0% |
| Q1 2014 | $19,934,000 | -64.9% | 309,681 | -65.2% | 0.01% | -68.8% |
| Q4 2013 | $56,819,000 | +36.9% | 890,283 | +28.6% | 0.02% | +166.7% |
| Q3 2013 | $41,502,000 | +144.2% | 692,392 | +100.4% | 0.01% | +20.0% |
| Q2 2013 | $16,998,000 | – | 345,470 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |